Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Perspective Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −8 vs. Q2 2022
- Shares held
- 16.1M
- −704.2K (−4.2%) vs. Q2 2022
- Total value
- $3.70M
- −$1.49M (−28.7%) vs. Q2 2022
- New holders
- 0
- 3 more added
- Sold out
- 8
- 13 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CATX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $297.6M |
| Q1 2026 | 138 | $333.1M |
| Q4 2025 | 117 | $105.0M |
| Q3 2025 | 105 | $150.1M |
| Q2 2025 | 98 | $146.3M |
| Q1 2025 | 112 | $96.4M |
| Q4 2024 | 135 | $150.7M |
| Q3 2024 | 127 | $654.9M |
| Q2 2024 | 105 | $384.9M |
| Q1 2024 | 104 | $294.6M |
| Q4 2023 | 52 | $14.7M |
| Q3 2023 | 49 | $9.99M |
| Q2 2023 | 50 | $22.0M |
| Q1 2023 | 42 | $17.8M |
| Q4 2022 | 48 | $4.26M |
| Q3 2022 | 35 | $3.70M |
| Q2 2022 | 43 | $5.19M |
| Q1 2022 | 39 | $5.79M |
| Q4 2021 | 45 | $6.78M |
| Q3 2021 | 43 | $9.99M |
| Q2 2021 | 48 | $13.9M |
| Q1 2021 | 57 | $20.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Perspective Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 680 | $0 | 0.00% | −16,778−96.1% | Reduced |
| Arcadia Investment Advisors LLC | 222 | $51 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 2,000 | $540 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 6,223 | $1.00K | 0.00% | −8−0.1% | Reduced |
| JNBA Financial Advisors | 5,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 15,000 | $3.00K | 0.00% | −3,000−16.7% | Reduced |
| Auxier Asset Management | 14,218 | $3.00K | 0.00% | 00.0% | Unchanged |
| Great Valley Advisor Group, Inc. | 12,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Victory Capital Management Inc | 15,965 | $4.00K | 0.00% | −3,989−20.0% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 17,500 | $4.00K | 0.00% | 00.0% | Unchanged |
| Capital Advisors Inc | 10,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 21,959 | $5.00K | 0.00% | −15,307−41.1% | Reduced |
| TMD Wealth Management, LLC | 20,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 25,905 | $6.00K | 0.00% | −15,115−36.8% | Reduced |
| Commonwealth Equity Services, LLC | 27,284 | $6.00K | 0.00% | +1,000+3.8% | Added |
| Royal Bank of Canada | 25,141 | $6.00K | 0.00% | +141+0.6% | Added |
| Bremer Bank National Association | 29,411 | $7.00K | 0.00% | 00.0% | Unchanged |
| WCG Wealth Advisors LLC | 34,022 | $8.00K | 0.00% | 00.0% | Unchanged |
| Cerity Partners LLC | 40,000 | $9.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 44,500 | $10.0K | 0.00% | −9,900−18.2% | Reduced |
| Crestwood Advisors Group LLC | 54,824 | $13.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 77,229 | $18.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 84,027 | $19.0K | 0.00% | −320.0% | Reduced |
| Wealth Effects LLC | 110,000 | $25.0K | 0.02% | +100,000+1,000.0% | Added |
| Creative Planning | 129,500 | $30.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 184,000 | $42.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 244,360 | $56.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 372,126 | $86.0K | 0.00% | −4,966−1.3% | Reduced |
| State Street Corp | 553,619 | $127.0K | 0.00% | 00.0% | Unchanged |
| Bard Associates Inc | 667,700 | $154.0K | 0.07% | −1,500−0.2% | Reduced |
| Taylor & Morgan Wealth Management, LLC | 770,354 | $177.0K | 0.18% | −5,000−0.6% | Reduced |
| Geode Capital Management, LLC | 1,131,105 | $260.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,443,344 | $562.0K | 0.00% | −2,009−0.1% | Reduced |
| Perkins Capital Management Inc | 2,850,644 | $655.0K | 0.73% | −63,856−2.2% | Reduced |
| Vanguard Group Inc | 6,047,815 | $1.39M | 0.00% | 00.0% | Unchanged |
| Venator Capital Management Ltd. | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −35,327−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −31,729−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −24,471−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −20,774−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Chilton Capital Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −82−100.0% | Sold out |